International Flavors & Fragrances Inc. (IFF)
NYSE: IFF · Real-Time Price · USD
65.82
+0.10 (0.15%)
At close: Aug 15, 2025, 4:00 PM
65.83
+0.01 (0.02%)
After-hours: Aug 15, 2025, 7:42 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Nourish | 5.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nourish Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health & Biosciences | 2.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health & Biosciences Growth | 5.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scent | 2.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scent Growth | -1.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Solutions | 961.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Solutions Growth | -11.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Nourish Capital Expenditures | 235.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nourish Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health & Biosciences Capital Expenditures | 73.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health & Biosciences Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scent Capital Expenditures | 70.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scent Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Solutions Capital Expenditures | 85.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Solutions Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Nourish Adjusted Operating EBITDA | 824.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nourish Adjusted Operating EBITDA Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health & Biosciences Adjusted Operating EBITDA | 654.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health & Biosciences Adjusted Operating EBITDA Growth | 3.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scent Adjusted Operating EBITDA | 518.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scent Adjusted Operating EBITDA Growth | -9.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Solutions Adjusted Operating EBITDA | 209.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Solutions Adjusted Operating EBITDA Growth | 3.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|